Plenary Lecture

  • Plenary Lecture 1 Implementing a comprehensive translational oncology platform in precision medicine: challenges, opportunities, and new directions
    Gordon B. MILLS Knight Cancer Institute USA CV
  • Plenary Lecture 2 Functional genomics approaches to identify targetable dependencies in cancer cells
    Mathew J. GARNETT Wellcome Sanger Institute UK CV
  • Plenary Lecture 3 Therapeutic targeting of the TAM receptor family in cancer
    Amato GIACCIA Oxford Institute of Radiation Oncology UK CV

Noe Kyeong Kim Memorial Award & Lecture Lecture

Noe Kyeong Kim Memorial Award & Lecture Clinical investigation for the management of advanced gastrointestinal stromal tumor (GIST)
  • Yoon-Koo KANG Asan Medical Center Korea CV

Special Symposium

Special Symposium 1 Opening a new chapter in clinical research of Korea BioPharm
  • Jung Won WOO Genexine, Inc. Korea CV
  • SeungJae BAEK Hanmi Pharmaceuticals Korea CV
  • Sunbae LEE Alteogen, Inc. Korea CV
  • Jin-San YOO PharmAbcine Inc. Korea CV

Scientific Symposium

Scientific Symposium 1 Cutting edge of immuno-oncology
  • Dae Ho LEE Asan Medical Center Korea
  • Han Chong TOH National Cancer Centre Singapore Singapore
  • Shigehisa KITANO The Cancer Institute Hospital of JFCR Japan CV
Scientific Symposium 2 GU cancers
  • Hyo Jin LEE Chungnam National University Hospital Korea CV
  • Seok Jae HUH Dong-A University Hospital Korea
  • Jae Young JOUNG National Cancer Center Korea
Scientific Symposium 3 The evolving landscape of systemic treatment of NSCLC
  • Helena A. Yu Memorial Sloan Kettering Cancer Center USA CV
  • Dong-Wan KIM Seoul National University Hospital Korea CV
  • Hye-Ryun KIM Yeonsei Cancer Center Korea CV
  • Solange PETERS Lausanne University Hospital Switzerland CV
Scientific Symposium 4 Functional genomics
  • Jin Billy LI Stanford University USA CV
  • Yongsub KIM Asan Medical Center Korea CV
  • Murim CHOI Seoul National University Korea CV
  • Mathew J. GARNETT Wellcome Sanger Institute UK CV
Scientific Symposium 5 Progress in precision medicine
  • Emile VOEST Netherlands Cancer Institute Netherlands CV
  • Yasuhiro FUJIWARA Pharmaceuticals and Medical Devices Agency Japan CV
  • Tae Min KIM Seoul National University Hospital Korea CV
  • Kyung Won KIM Asan Medical Center Korea CV
Scientific Symposium 6 CRC
  • Scott KOPETZ The University of Texas MD Anderson Cancer Center USA CV
  • Yongjun CHA National Cancer Center Korea CV
  • Soohyeon LEE Korea University Anam Hospital Korea CV
Scientific Symposium 7 Breast cancer
  • Lajos PUSZTAI Yale Cancer Center USA CV
  • Gregory VIDAL West Cancer Center USA CV
Scientific Symposium 8 GC/HBP cancers
  • Do-Youn OH Seoul National University Hospital Korea CV
  • Joon Oh PARK Samsung Medical Center Korea CV
  • Li-Tzong CHEN National Institute of Cancer Research Taiwan
  • Baek-Yeol RYOO Asan Medical Center Korea CV
Scientific Symposium 9 Discovery of novel therapeutic targets
  • Gerald FALCHOOK Sarah Cannon Research Institute in Denver USA CV
  • Amato GIACCIA Oxford Institute of Radiation Oncology UK CV
  • Hwan Jung LIM Korea Research Institute of Chemical Technology Korea CV

Joint Symposium

ASCO/KSMO Joint Symposium Accelerating precision medicine in real-world and utilizing real-world evidence
  • Richard L. SCHILSKY American Society of Clinical Oncology USA CV
  • Jee Hyun KIM Seoul National University Bundang Hospital Korea CV
  • Cory D. WIEGERT CancerLinQ LLC USA CV
  • Robert S. MILLER ASCO CancerLinQ USA CV
  • Dae Young ZANG Hallym University Medical Center Korea CV
KOSRO/KSMO Joint Symposium Role of local radiotherapy in the metastatic setting
  • Hai-Qiang MAI Sun Yat-sen University Cancer Center China CV
  • Won PARK Samsung Medical Center Korea CV
  • Su Ssan KIM Asan Medical Center Korea CV
KCSG/KSMO Joint Symposium Expanding the field of clinical trials to fulfill unmet clinical needs
  • Kun WANG Guangdong Provincial People's Hospital China CV
  • Joohyuk SOHN Yonsei Cancer Center Korea CV
  • Sang-Yoon LEE Interpark Bio-Convergence Center Korea CV
KSSO/KSMO Joint Symposium Evolving role of surgery in a multidisciplinary approach
  • Keun-Wook LEE Seoul National University Bundang Hospital Korea CV
  • Han-Kwang YANG Seoul National University Hospital Korea CV
  • Myung Ah LEE The Catholic University of Korea Seoul St. Mary's Hospital Korea CV
  • Woo Yong LEE Samsung Medical Center Korea CV
JSMO/KSMO Joint Symposium Clinical genomics: Challenges and opportunities
  • Koichi GOTO National Cancer Center Hospital East Japan
  • Se-Hoon LEE Samsung Medical Center Korea CV
  • Yosuke TOGASHI Chiba Cancer Center Japan CV
  • Woong-Yang PARK Samsung Genome Institute Korea CV
KSP/KSMO Joint Symposium Updated cancer diagnosis platform: Present and future
  • Jin ROH Ajou University Hospital Korea CV
  • Kee-Taek JANG Samsung Medical Center Korea CV
  • Kate E. YU VPIX Medical Korea CV
  • Chaithanya CHELAKKOT GenoBio Korea CV

Multidisciplinary Oncology Team Education Session

Oncology Multi-Disciplinary Symposium 면역항암제의 보험시대에 임상에서 확인되는 현실적인 이슈들
  • Dong Seok HAN Seoul National University Boramae Medical Center Korea
  • Ho Yun LEE Samsung Medical Center Korea CV
  • Ii Hwan KIM Inje University Haeundae Paik Hospital Korea CV
  • Si Yeol SONG Asan Medical Center Korea CV
  • Hyo Sup SHIM Severance Hospital Korea CV
Multidisciplinary Oncology Team Education Session 1 Understanding new paradigms of oncology clinical research & practice
  • Jihoon KANG Kangbuk Samsung Hospital Korea CV
  • In-Ho KIM The Catholic University of Korea Seoul St. Mary's Hospital Korea CV
  • Yoon Ji CHOI Korea University Anam Hospital Korea CV
Multidisciplinary Oncology Team Education Session 2 Precision medicine in real-world
  • Min Hee HONG Severance Hospital Korea CV
  • Yun-Gyoo LEE Kangbuk Samsung Hospital Korea CV
  • JungHyun KIM Samsung Medical Center Korea CV
Multidisciplinary Oncology Team Education Session 3 Multidisciplinary approaches in immuno-oncology incorporated into clinical practice
  • Soo Jung LEE Kyungpook National University Chilgok Hospital Korea CV
  • Chi Hoon MAENG Kyung Hee University Hospital Korea CV
  • Shinkyo YOON Asan Medical Center Korea CV

ASCO Breakthrough Session

ASCO Breakthrough Session KSMO-ASCO breakthrough insights: Bench to bedside research in oncology
  • Shiladitya SENGUPTA Harvard Medical School USA
  • Young Seok JU KAIST Korea CV
  • Siew C NG The Chinese University of Hong Kong Hong Kong CV

FACO Session

FACO Session 1 Update of FACO clinical trials
  • Shigeru IMOTO Kyorin University Japan CV
  • Junji FURUSE Kyorin University Japan CV
FACO Session 2 Advance of immuno-oncologic strategies for Asian cancer patients
  • Hee Kyung AHN Gachon University Gil Medical Center Korea
  • Xiaotian ZHANG Peking University Cancer Hospital China CV
  • Toshimi TAKANO The Cancer Institute Hospital of JFCR Japan CV

Luncheon Symposium

Luncheon Symposium 1
MSD
MSI- H (High microsatellite instability) : Predictive biomarkers in the era of precision medicine
  • Seung Tae KIM Samsung Medical Center Korea CV
Luncheon Symposium 2
Roche
Treatment paradigm shift in HCC: the combination revolution in IMbrave150
  • Baek-Yeol RYOO Asan Medical Center Korea CV
Luncheon Symposium 3
Novartis
Treatment landscape for HR+/HER2- aBC: focusing on CDK4/6 pathway
  • Seock-Ah IM Seoul National University Hospital Korea
Luncheon Symposium 4
Astrazeneca
Cutting-edge front-line treatment for advanced non-small cell lung cancer
  • Stephen CLARKE Royal North Shore Hospital Australia CV

Satellite Symposium

Satellite Symposium 1
Servier  Boryung
Future insight for the management of pancreatic and biliary tract cancers
  • Chang-hoon YOO Asan medical center Korea CV
Satellite Symposium 2
MSD
The current and future challenges: Good luck does not always repeat
Satellite Symposium 3
Roche
The beginning of immunotherapy journey in breast cancer
  • Seock-Ah Im Seoul National University Hospital Korea
Satellite Symposium 4
Eisai
Lenvatinib treatment in first line uHCC and subsequent treatments
  • Stephen L. Chan The Chinese University of Hong Kong Hong Kong CV
  • Chang-hoon YOO Asan medical center Korea CV
Satellite Symposium 5
Amgen
Importance of bone health management in palliative setting
  • In-Ho KIM The Catholic University of Korea Seoul St. Mary's Hospital Korea CV
  • Ji-Yeon KIM Samsung Medical Center Korea CV
Satellite Symposium 6
Menarini
Satellite Symposium 7
Sanofi
What is being considered for continuum of care in metastatic colorectal cancer?
  • Seunghoon Beom Yonsei University Korea CV
Satellite Symposium 8
Merck
Satellite Symposium 9
Pfizer
New Perspectives for Treatment naïve patients with EGFR+ Non Small Cell Lung Cancer
  • Hye-Ryun KIM Yeonsei Cancer Center Korea CV
  • Mok Shu Kam TONY The Chinese University of Hong Kong Hong Kong
Satellite Symposium 10
Lilly
Continuing Advances in metastatic Breast Cancer: How to make optimal treatment decision for metastatic breast cancer patients
  • Gregory Vidal Western Cancer Center USA CV
Satellite Symposium 11
Takeda
Treatment options for patients with ALK+ NSCLC: How is the paradigm changing?
  • Mok Shu Kam TONY The Chinese University of Hong Kong Hong Kong
Satellite Symposium 12
ONO / BMS
Ever forward with cancer immunotherapy : the progress so far and new frontiers
  • Sun Min LIM Yonsei Cancer Center Korea CV
Satellite Symposium 13
MSD
From concept to practice - new era of precision medicine
  • Do-Youn OH Seoul National University Hospital Korea CV
Satellite Symposium 14
samsung  Daewoong
Building confidence in Biosimilars: From data to patient
  • Seongwon HAN Samsung Bioepis Korea CV